Jarle Bruun

3.3k total citations · 1 hit paper
32 papers, 2.1k citations indexed

About

Jarle Bruun is a scholar working on Oncology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Jarle Bruun has authored 32 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 13 papers in Molecular Biology and 13 papers in Pathology and Forensic Medicine. Recurrent topics in Jarle Bruun's work include Genetic factors in colorectal cancer (12 papers), Colorectal Cancer Treatments and Studies (8 papers) and Cancer Genomics and Diagnostics (8 papers). Jarle Bruun is often cited by papers focused on Genetic factors in colorectal cancer (12 papers), Colorectal Cancer Treatments and Studies (8 papers) and Cancer Genomics and Diagnostics (8 papers). Jarle Bruun collaborates with scholars based in Norway, Finland and Sweden. Jarle Bruun's co-authors include Ragnhild A. Lothe, Anita Sveen, Peter W. Eide, Arild Nesbakken, Patrick Micke, Artur Mezheyeuski, Stine A. Danielsen, Guro E. Lind, Ina A. Eilertsen and Allen W. Zhang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Cancer Research.

In The Last Decade

Jarle Bruun

32 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cancer stemness, intratumoral heterogeneity, and immune response across cancers

2019 392 citations Alex Miranda, Phineas T. Hamilton et al. Proceedings of the National Academy of Sciences profile →

Peers

Countries citing papers authored by Jarle Bruun

Since Specialization

Citations

This map shows the geographic impact of Jarle Bruun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jarle Bruun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jarle Bruun more than expected).

Fields of papers citing papers by Jarle Bruun

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jarle Bruun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jarle Bruun. The network helps show where Jarle Bruun may publish in the future.

Co-authorship network of co-authors of Jarle Bruun

This figure shows the co-authorship network connecting the top 25 collaborators of Jarle Bruun. A scholar is included among the top collaborators of Jarle Bruun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jarle Bruun. Jarle Bruun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The prognostic effect of tumor-associated macrophages in stage I-III colorectal cancer depends on T cell infiltration 2024 ·Cellular Oncology ·(unknown), Christian H. Bergsland, Anita Sveen, Jarle Bruun, Ina A. Eilertsen, Espen S. Bækkevold, Arild Nesbakken, Sheraz Yaqub, Frode L. Jahnsen, Ragnhild A. Lothe	6
2	Prognostic role of tumour-infiltrating lymphocytes and macrophages in relation to MSI, CDX2 and BRAF status: a population-based study of metastatic colorectal cancer patients 2021 ·British Journal of Cancer ·(unknown), Jarle Bruun, Christian H. Bergsland, Luís Nunes, Geir Egil Eide, Per Pfeiffer, Olav Dahl, Bengt Glimelius, Ragnhild A. Lothe, Halfdan Sørbye	11
3	E‐cadherin is a robust prognostic biomarker in colorectal cancer and low expression is associated with sensitivity to inhibitors of topoisomerase, aurora, and HSP90 in preclinical models 2021 ·Molecular Oncology ·Jarle Bruun, Peter W. Eide, Christian H. Bergsland, Oscar Brück, Aud Svindland, Mariliina Arjama, Katja Välimäki, Merete Bjørnslett, Marianne G. Guren, Olli Kallioniemi, Arild Nesbakken, Ragnhild A. Lothe, Teijo Pellinen	9
4	Prediction of relapse-free survival according to adjuvant chemotherapy and regulator of chromosome condensation 2 (RCC2) expression in colorectal cancer 2020 ·ESMO Open ·Christian H. Bergsland, Jarle Bruun, Marianne G. Guren, Aud Svindland, Merete Bjørnslett, (unknown), Merete Hektoen, Matthias Kolberg, Enric Domingo, Teijo Pellinen, Ian Tomlinson, David Kerr, David N. Church, Arild Nesbakken, Anita Sveen, Ragnhild A. Lothe	6
5	A panel of intestinal differentiation markers (CDX2, GPA33, and LI-cadherin) identifies gastric cancer patients with favourable prognosis 2020 ·Gastric Cancer ·Nair Lopes, Christian H. Bergsland, Jarle Bruun, Merete Bjørnslett, André Filipe Vieira, Patrícia Mesquita, (unknown), (unknown), Bruno Cavadas, Eric Bennett, Luı́sa Pereira, Ragnhild A. Lothe, Raquel Almeida, Leonor David	22
6	Cancer stemness, intratumoral heterogeneity, and immune response across cancers breakdown → 2019 ·Proceedings of the National Academy of Sciences ·Alex Miranda, Phineas T. Hamilton, Allen W. Zhang, Swetansu Pattnaik, Étienne Becht, Artur Mezheyeuski, Jarle Bruun, Patrick Micke, Aurélien de Reyniès, Brad H. Nelson	392
7	Exploratory analyses of consensus molecular subtype-dependent associations of TP53 mutations with immunomodulation and prognosis in colorectal cancer 2019 ·ESMO Open ·(unknown), Anita Sveen, Christian H. Bergsland, Ina A. Eilertsen, Stine A. Danielsen, Peter W. Eide, Merete Hektoen, Marianne G. Guren, Arild Nesbakken, Jarle Bruun, Ragnhild A. Lothe	13
8	Digital image analysis of multiplex fluorescence IHC in colorectal cancer recognizes the prognostic value of CDX2 and its negative correlation with SOX2 2019 ·Laboratory Investigation ·Nair Lopes, Christian H. Bergsland, Merete Bjørnslett, Teijo Pellinen, Aud Svindland, Arild Nesbakken, Raquel Almeida, Ragnhild A. Lothe, Leonor David, Jarle Bruun	21
9	Colorectal Cancer Consensus Molecular Subtypes Translated to Preclinical Models Uncover Potentially Targetable Cancer Cell Dependencies 2017 ·Clinical Cancer Research ·Anita Sveen, Jarle Bruun, Peter W. Eide, Ina A. Eilertsen, Lorena Ramírez, Astrid Murumägi, Mariliina Arjama, Stine A. Danielsen, Kushtrim Kryeziu, Élena Elez, Josep Tabernero, Justin Guinney, Héctor G. Pálmer, Arild Nesbakken, Olli Kallioniemi, Rodrigo Dienstmann, Ragnhild A. Lothe	173
10	CMScaller: an R package for consensus molecular subtyping of colorectal cancer pre-clinical models 2017 ·Scientific Reports ·Peter W. Eide, Jarle Bruun, Ragnhild A. Lothe, Anita Sveen	189
11	Multi-omics of 34 colorectal cancer cell lines - a resource for biomedical studies 2017 ·Molecular Cancer ·Kaja C. G. Berg, Peter W. Eide, Ina A. Eilertsen, Bjarne Johannessen, Jarle Bruun, Stine A. Danielsen, Merete Bjørnslett, Leonardo A. Meza‐Zepeda, Mette Eknæs, Guro E. Lind, Ola Myklebost, Rolf I. Skotheim, Anita Sveen, Ragnhild A. Lothe	284
12	Regulator of Chromosome Condensation 2 Identifies High-Risk Patients within Both Major Phenotypes of Colorectal Cancer 2015 ·Clinical Cancer Research ·Jarle Bruun, Matthias Kolberg, Terje Ahlquist, Ellen C. Røyrvik, Torfinn Nome, Edward Leithe, Guro E. Lind, Marianne A. Merok, Torleiv O. Rognum, Geir Bjørkøy, Terje Johansen, Annika Lindblom, Sun Xiao, Aud Svindland, Knut Liestøl, Arild Nesbakken, Rolf I. Skotheim, Ragnhild A. Lothe	38
13	Identification of Novel Fusion Genes in Testicular Germ Cell Tumors 2015 ·Cancer Research ·Andreas Hoff, Sharmini Alagaratnam, Sen Zhao, Jarle Bruun, Peter W. Andrews, Ragnhild A. Lothe, Rolf I. Skotheim	19
14	Exome Sequencing of Bilateral Testicular Germ Cell Tumors Suggests Independent Development Lineages 2015 ·Neoplasia ·(unknown), Bjarne Johannessen, Ulrika Axcrona, Sigrid Marie Kraggerud, (unknown), Anne Cathrine Bakken, Jarle Bruun, Sophie D. Fosså, Ragnhild A. Lothe, Gustav Lehne, Rolf I. Skotheim	8
15	Prognostic Significance of Î²-Catenin, E-Cadherin, and SOX9 in Colorectal Cancer: Results from a Large Population-Representative Series 2014 ·Frontiers in Oncology ·Jarle Bruun, Matthias Kolberg, Jahn M. Nesland, Aud Svindland, Arild Nesbakken, Ragnhild A. Lothe	68
16	Common Fusion Transcripts Identified in Colorectal Cancer Cell Lines by High-Throughput RNA Sequencing 2013 ·Translational Oncology ·Torfinn Nome, (unknown), Jarle Bruun, Terje Ahlquist, Anne Cathrine Bakken, Andreas Hoff, Torleiv O. Rognum, Arild Nesbakken, Susanne Lorenz, Jinchang Sun, João D. Barros‐Silva, Guro E. Lind, Ola Myklebost, Manuel R. Teixeira, Leonardo A. Meza‐Zepeda, Ragnhild A. Lothe, Rolf I. Skotheim	24
17	NEDD4 is overexpressed in colorectal cancer and promotes colonic cell growth independently of the PI3K/PTEN/AKT pathway 2012 ·Cellular Signalling ·Peter W. Eide, Lina Cekaite, Stine A. Danielsen, Ina A. Eilertsen, Ane Kjenseth, Tone A. Fykerud, Trude H. Ågesen, Jarle Bruun, Edgar Rivedal, Ragnhild A. Lothe, Edward Leithe	63
18	The Gap Junction Channel Protein Connexin 43 Is Covalently Modified and Regulated by SUMOylation 2012 ·Journal of Biological Chemistry ·Ane Kjenseth, Tone A. Fykerud, Solveig Sirnes, Jarle Bruun, (unknown), Matthias Kolberg, Yasufumi Omori, Edgar Rivedal, Edward Leithe	55
19	Connexin43 acts as a colorectal cancer tumor suppressor and predicts disease outcome 2011 ·International Journal of Cancer ·Solveig Sirnes, Jarle Bruun, Matthias Kolberg, Ane Kjenseth, Guro E. Lind, Aud Svindland, Andreas Brech, Arild Nesbakken, Ragnhild A. Lothe, Edward Leithe, Edgar Rivedal	103
20	Inhibition of connexin43 gap junction channels by the endocrine disruptor ioxynil 2010 ·Toxicology and Applied Pharmacology ·Edward Leithe, Ane Kjenseth, Jarle Bruun, Solveig Sirnes, Edgar Rivedal	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact